Summit Therapeutics Inc. (SMMT)
NASDAQ: SMMT · Real-Time Price · USD
18.62
-1.38 (-6.90%)
Nov 20, 2024, 4:00 PM EST - Market open
Summit Therapeutics Market Cap
Summit Therapeutics has a market cap or net worth of $13.57 billion as of November 21, 2024. Its market cap has increased by 911.31% in one year.
Market Cap
13.57B
Enterprise Value
13.28B
1-Year Change
911.31%
Ranking
Category
Stock Price
$18.41
Market Cap Chart
Since March 5, 2015, Summit Therapeutics's market cap has increased from $119.00M to $13.57B, an increase of 11,305.66%. That is a compound annual growth rate of 62.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 13.73B | 650.67% |
| Dec 29, 2023 | 1.83B | 113.79% |
| Dec 30, 2022 | 855.60M | 225.45% |
| Dec 31, 2021 | 262.90M | -32.00% |
| Dec 31, 2020 | 386.60M | 653.61% |
| Dec 31, 2019 | 51.30M | 203.55% |
| Dec 31, 2018 | 16.90M | -87.66% |
| Dec 29, 2017 | 137.00M | 30.60% |
| Dec 30, 2016 | 104.90M | -21.83% |
| Dec 31, 2015 | 134.20M | 12.77% |
| Mar 5, 2015 | 119.00M | - |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ICON Public Limited Company | 16.60B |
| Align Technology | 16.53B |
| United Therapeutics | 16.10B |
| Viatris | 15.74B |
| Royalty Pharma | 15.42B |
| Moderna | 14.49B |
| Tenet Healthcare | 14.47B |
| Incyte | 13.75B |